This is a Validated Antibody Database (VAD) review about human IGF-IR, based on 122 published articles (read how Labome selects the articles), using IGF-IR antibody in all methods. It is aimed to help Labome visitors find the most suited IGF-IR antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
IGF-IR synonym: CD221; IGFIR; IGFR; JTK13

Knockout validation
Cell Signaling Technology
domestic rabbit monoclonal (D23H3)
  • western blot knockout validation; human; 1:1000; loading ...; fig 4i, s5n
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot knockout validation on human samples at 1:1000 (fig 4i, s5n). Nat Commun (2021) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig 7f
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3027) was used in western blot knockout validation on mouse samples (fig 7f). Adv Sci (Weinh) (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D23H3)
  • western blot knockout validation; mouse; loading ...; fig 1a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750S) was used in western blot knockout validation on mouse samples (fig 1a). Mol Metab (2021) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (D23H3)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 1a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot knockout validation on mouse samples at 1:1000 (fig 1a). PLoS ONE (2019) ncbi
Invitrogen
mouse monoclonal (1H7)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen IGF-IR antibody (Thermo Fisher, 17-8849-42) was used in flow cytometry on human samples (fig 1a). Int J Mol Sci (2020) ncbi
mouse monoclonal (1H7)
  • flow cytometry; human; fig 3f
Invitrogen IGF-IR antibody (Life Technologies, 17-8849-42) was used in flow cytometry on human samples (fig 3f). Cell (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 4i
In order to show that DNA hypermethylation at the PPARgamma1 promoter is induced by obesity-related factors, Invitrogen IGF-IR antibody (Invitrogen, 44-804G) was used in western blot on mouse samples (fig 4i). JCI Insight (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...
In order to generate and characterize an antibody that is specific for the insulin receptor and evaluate its effect on diabetic pathogenesis, Invitrogen IGF-IR antibody (Invitrogen, 44802G) was used in western blot on human samples . Diabetes (2017) ncbi
domestic rabbit polyclonal
  • other; human; fig 7
In order to research a novel method of differential ligand activation and phosphatase-mediated deactivation of insulin receptor tyrosine-specific phosphorylation, Invitrogen IGF-IR antibody (Invitrogen, 44802G) was used in other on human samples (fig 7). Cell Signal (2016) ncbi
mouse monoclonal (24-31)
  • immunohistochemistry - frozen section; human; 1:100; fig 4b
  • immunocytochemistry; human; 4 ug/ml; loading ...; fig 1b
In order to test if fluorescently labeled insulin-like growth factor-1 receptor antibodies can be used to visualize pancreatic cancer in orthotopic nude mouse models, Invitrogen IGF-IR antibody (Thermo Scientific, 24-31) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 4b) and in immunocytochemistry on human samples at 4 ug/ml (fig 1b). Oncotarget (2016) ncbi
mouse monoclonal (24-31)
  • immunocytochemistry; human; loading ...; fig 1b
In order to test if insulin-like growth factor-1 receptor antibodies enable the visualization of metastatic colon cancer in orthotopic nude mouse models, Invitrogen IGF-IR antibody (Thermo Scientific, 24-31) was used in immunocytochemistry on human samples (fig 1b). PLoS ONE (2016) ncbi
domestic rabbit recombinant (15H10L8)
  • western blot; human; 1:500; fig 1
In order to assess microRNA-122 and sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways, Invitrogen IGF-IR antibody (life technologies, 701067) was used in western blot on human samples at 1:500 (fig 1). Cancer Lett (2016) ncbi
domestic rabbit polyclonal
In order to investigate the effect of heat shock on glucose metabolism by skeletal muscles, Invitrogen IGF-IR antibody (Life Technologies, 44-806G) was used . Physiol Rep (2015) ncbi
domestic rabbit recombinant (97H9L7)
  • western blot; mouse; loading ...; fig 1c
In order to describe how PTP1B is a mechanism-based therapeutic target for Rett syndrome, Invitrogen IGF-IR antibody (Invitrogen, 700393) was used in western blot on mouse samples (fig 1c). J Clin Invest (2015) ncbi
domestic rabbit polyclonal
In order to study mechanisms that confer resistance to therapeutic interventions in the insulin-like growth factor receptor pathway, Invitrogen IGF-IR antibody (invitrogen, 44-804G) was used . Mol Cancer (2015) ncbi
domestic rabbit polyclonal
In order to investigate the effects of nicotinamide adenine dinucleotide phosphate reduced oxidase 4 in liver tissues from patients with NASH and mice with steatohepatitis, Invitrogen IGF-IR antibody (Invitrogen, 44-804G) was used . Gastroenterology (2015) ncbi
mouse monoclonal (ZI001)
  • western blot; human; fig 3
In order to analyze NPM-ALK+ T-cell lymphoma and the transcription factors MZF1 and Ik-1 that downregulate IGF-IR expression, Invitrogen IGF-IR antibody (Life Technologies, 396700) was used in western blot on human samples (fig 3). Mol Cancer (2015) ncbi
domestic rabbit polyclonal
In order to study the structures of the insulin receptor and the insulin-like growth factor-1 receptor, Invitrogen IGF-IR antibody (Life Technologies, 44804G) was used . Nat Commun (2015) ncbi
mouse monoclonal (ZI001)
  • western blot; human
In order to determine the effects of ASP3026treatment on NPM-ALK+ ALCL cell lines in vitro and on systemic lymphoma growth in vivo, Invitrogen IGF-IR antibody (Invitrogen, 39-6700) was used in western blot on human samples . Oncotarget (2014) ncbi
mouse monoclonal (24-31)
  • immunohistochemistry - paraffin section; human; 1:25
In order to discuss mechanisms that link metabolic syndrome to colorectal cancer risk, Invitrogen IGF-IR antibody (Invitrogen, AHR0321) was used in immunohistochemistry - paraffin section on human samples at 1:25. J Geriatr Oncol (2014) ncbi
mouse monoclonal (24-31)
  • immunohistochemistry - paraffin section; human; 1:200; fig 1
In order to investigate the contribution of the PI3K/Akt pathway to trastuzumab resistance, Invitrogen IGF-IR antibody (Neomarkers, 24-31) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1). Br J Cancer (2012) ncbi
mouse monoclonal (ZI001)
  • western blot; human; fig 3
In order to study regulation of anaplastic lymphoma kinase expression in cancer cells, Invitrogen IGF-IR antibody (Zymed, 39-6700) was used in western blot on human samples (fig 3). Am J Pathol (2012) ncbi
mouse monoclonal (24-31)
  • immunohistochemistry - paraffin section; human; 1:50; tbl 1
In order to study the category subdivision of pT1a and pT1b in renal cell carcinoma, Invitrogen IGF-IR antibody (Neomarkers, 24-31) was used in immunohistochemistry - paraffin section on human samples at 1:50 (tbl 1). BJU Int (2005) ncbi
Santa Cruz Biotechnology
mouse monoclonal (3G5C1)
  • immunohistochemistry; human; loading ...; fig 2a
Santa Cruz Biotechnology IGF-IR antibody (Santa Cruz Biotechnology, sc-81167) was used in immunohistochemistry on human samples (fig 2a). Front Endocrinol (Lausanne) (2021) ncbi
mouse monoclonal (7G11)
  • immunohistochemistry; mouse; loading ...; fig 2
  • western blot; mouse; loading ...; fig 3
Santa Cruz Biotechnology IGF-IR antibody (Santa cruz, sc-81464) was used in immunohistochemistry on mouse samples (fig 2) and in western blot on mouse samples (fig 3). Aging (Albany NY) (2020) ncbi
mouse monoclonal (7G11)
  • western blot; human; loading ...; fig 3a
Santa Cruz Biotechnology IGF-IR antibody (Santa Cruz, 7G11) was used in western blot on human samples (fig 3a). Cells (2020) ncbi
mouse monoclonal (F-1)
  • western blot; mouse; 1:200; loading ...; fig 1h
Santa Cruz Biotechnology IGF-IR antibody (Santa Cruz, sc-390130) was used in western blot on mouse samples at 1:200 (fig 1h). EMBO Mol Med (2020) ncbi
mouse monoclonal (2C8)
  • western blot; mouse; loading ...; fig 3a
Santa Cruz Biotechnology IGF-IR antibody (Santa Cruz, sc-463) was used in western blot on mouse samples (fig 3a). Int J Mol Sci (2017) ncbi
  • immunohistochemistry; mouse; fig 1
  • western blot; mouse; fig 1
Santa Cruz Biotechnology IGF-IR antibody (Santa Cruz, sc713) was used in immunohistochemistry on mouse samples (fig 1) and in western blot on mouse samples (fig 1). Physiol Rep (2016) ncbi
  • western blot; human; 1:1000; loading ...; fig 5a
In order to delineate the mechanism for lung tumorigenesis by a tobacco-specific carcinogen, Santa Cruz Biotechnology IGF-IR antibody (Santa Cruz, sc-713) was used in western blot on human samples at 1:1000 (fig 5a). Nat Commun (2016) ncbi
  • western blot; mouse; loading ...; fig 3a
Santa Cruz Biotechnology IGF-IR antibody (SantaCruz, sc-713) was used in western blot on mouse samples (fig 3a). Mol Carcinog (2017) ncbi
mouse monoclonal (3G5C1)
  • western blot; human; fig 1d
In order to elucidate the mechanisms by which cancer cells overcome anoikis, Santa Cruz Biotechnology IGF-IR antibody (Santa Cruz Biotechnology, sc-81167) was used in western blot on human samples (fig 1d). Cell Death Differ (2016) ncbi
mouse monoclonal (3B7)
  • western blot; human; fig 4
Santa Cruz Biotechnology IGF-IR antibody (Santa Cruz, sc-462) was used in western blot on human samples (fig 4). Oncol Lett (2015) ncbi
mouse monoclonal (3B7)
  • immunohistochemistry; mouse; 1:400; fig 4
In order to characterize attenuation of dystrophinopathy in humans and mice by translation from a DMD exon 5 IRES that results in a functional dystrophin isoform, Santa Cruz Biotechnology IGF-IR antibody (SantaCruz, sc-462) was used in immunohistochemistry on mouse samples at 1:400 (fig 4). Nat Med (2014) ncbi
Abcam
domestic rabbit monoclonal (EPR19322)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3d
Abcam IGF-IR antibody (Abcam, ab182408) was used in immunohistochemistry - paraffin section on mouse samples (fig 3d). Front Aging Neurosci (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:100; loading ...; fig 9a
Abcam IGF-IR antibody (Abcam, ab39398) was used in immunohistochemistry - paraffin section on mouse samples at 1:100 (fig 9a). Mol Med Rep (2022) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; human; fig 2b
Abcam IGF-IR antibody (Abcam, ab39398) was used in immunohistochemistry on human samples (fig 2b). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4j
Abcam IGF-IR antibody (Abcam, ab5681) was used in western blot on mouse samples at 1:1000 (fig 4j). Int J Mol Sci (2021) ncbi
domestic rabbit monoclonal (EPR19322)
  • immunohistochemistry; mouse; loading ...; fig 2
  • western blot; mouse; loading ...; fig 3
Abcam IGF-IR antibody (abcam, ab182408) was used in immunohistochemistry on mouse samples (fig 2) and in western blot on mouse samples (fig 3). Aging (Albany NY) (2020) ncbi
mouse monoclonal (alphaIR3)
  • immunohistochemistry - paraffin section; human; fig 2
  • flow cytometry; human; fig 1
  • western blot; human; fig s1
Abcam IGF-IR antibody (Abcam, ab16890) was used in immunohistochemistry - paraffin section on human samples (fig 2), in flow cytometry on human samples (fig 1) and in western blot on human samples (fig s1). PLoS ONE (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:100; fig 2
Abcam IGF-IR antibody (abcam, ab5681) was used in immunohistochemistry - frozen section on mouse samples at 1:100 (fig 2). Sci Rep (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4a
In order to research the effects of environmental tobacco smoke on autophagy and longevity, Abcam IGF-IR antibody (Abcam, ab-39398) was used in western blot on mouse samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 4a
In order to research the effects of environmental tobacco smoke on autophagy and longevity, Abcam IGF-IR antibody (Abcam, ab39675) was used in western blot on mouse samples (fig 4a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; fig s4
In order to determine stromal miR-143/145 microRNAs promote tumorigenesis, Abcam IGF-IR antibody (Abcam, ab39398) was used in immunohistochemistry - frozen section on mouse samples (fig s4). Cancer Discov (2016) ncbi
  • immunohistochemistry; mouse; fig 2
  • flow cytometry; human; fig s2
Abcam IGF-IR antibody (Abcam, ab131476) was used in immunohistochemistry on mouse samples (fig 2) and in flow cytometry on human samples (fig s2). J Am Heart Assoc (2015) ncbi
BioLegend
mouse monoclonal (1H7/CD221)
  • flow cytometry; human; loading ...; fig 2a
BioLegend IGF-IR antibody (Biolegend, 1H7/CD221) was used in flow cytometry on human samples (fig 2a). Bone Rep (2020) ncbi
mouse monoclonal (1H7/CD221)
  • flow cytometry; human
BioLegend IGF-IR antibody (Biolegend, 351805) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
Miltenyi Biotec
human monoclonal (REA271)
  • blocking or activating experiments; mouse; 1:10; loading ...; fig 1a
Miltenyi Biotec IGF-IR antibody (Miltenyi Biotech, REA271) was used in blocking or activating experiments on mouse samples at 1:10 (fig 1a). PLoS ONE (2018) ncbi
Cell Signaling Technology
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:1000; loading ...; fig 5a, 6b, s9a
  • western blot; human; 1:1000; loading ...; fig 2g
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on mouse samples at 1:1000 (fig 5a, 6b, s9a) and in western blot on human samples at 1:1000 (fig 2g). Nat Commun (2022) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; 1:1000; loading ...; fig 2f
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024S) was used in western blot on human samples at 1:1000 (fig 2f). Nature (2022) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; 1:1000; fig 2f
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750S) was used in western blot on human samples at 1:1000 (fig 2f). Nature (2022) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; loading ...; fig 2d
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot on human samples (fig 2d). Cell Oncol (Dordr) (2022) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples (fig 1b). Cell Oncol (Dordr) (2022) ncbi
domestic rabbit monoclonal (DA7A8)
  • western blot; mouse; loading ...; fig 5a, 5b
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3918) was used in western blot on mouse samples (fig 5a, 5b). Acta Neuropathol Commun (2022) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; mouse; loading ...; fig 5a, 5b
  • western blot; mouse; loading ...; fig 5a, 5b
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in immunoprecipitation on mouse samples (fig 5a, 5b) and in western blot on mouse samples (fig 5a, 5b). Acta Neuropathol Commun (2022) ncbi
domestic rabbit monoclonal (DA7A8)
  • western blot; human; 1:1000; loading ...; fig e8q, e9b
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3918S) was used in western blot on human samples at 1:1000 (fig e8q, e9b). Nature (2022) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; 1:500; loading ...; fig e8q, e9b
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750S) was used in western blot on human samples at 1:500 (fig e8q, e9b). Nature (2022) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot knockout validation; human; 1:1000; loading ...; fig 4i, s5n
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot knockout validation on human samples at 1:1000 (fig 4i, s5n). Nat Commun (2021) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; mouse; loading ...; fig 7f
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3027) was used in western blot knockout validation on mouse samples (fig 7f). Adv Sci (Weinh) (2021) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot on human samples at 1:1000 (fig 3c). J Immunother Cancer (2021) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; 1:1000; loading ...; fig 3c
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples at 1:1000 (fig 3c). J Immunother Cancer (2021) ncbi
monoclonal (D6D5L)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology IGF-IR antibody (cell signalling technology, 80732) was used in western blot on human samples at 1:1000 (fig 1a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (111A9)
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology IGF-IR antibody (cell signalling technology, 3018) was used in western blot on human samples at 1:1000 (fig 1a). Nat Commun (2021) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; loading ...; fig 7e
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on mouse samples (fig 7e). Sci Rep (2021) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:500; fig 4g
Cell Signaling Technology IGF-IR antibody (Cell signaling, 3024) was used in western blot on mouse samples at 1:500 (fig 4g). J Clin Invest (2021) ncbi
domestic rabbit monoclonal (111A9)
  • western blot; human; 1:2500; fig 3a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3018S) was used in western blot on human samples at 1:2500 (fig 3a). Cell Rep (2021) ncbi
domestic rabbit monoclonal (DA7A8)
  • western blot; human; 1:1000; fig 3a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3918S) was used in western blot on human samples at 1:1000 (fig 3a). Cell Rep (2021) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:1000; loading ...; fig 8b
Cell Signaling Technology IGF-IR antibody (Cell Signalling Technology, CST3024) was used in western blot on mouse samples at 1:1000 (fig 8b). Bone Res (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in western blot on mouse samples at 1:1000 (fig 4a). Cancer Sci (2021) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:1000; loading ...; fig 4a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on mouse samples at 1:1000 (fig 4a). Cancer Sci (2021) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot knockout validation; mouse; loading ...; fig 1a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750S) was used in western blot knockout validation on mouse samples (fig 1a). Mol Metab (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3i
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in western blot on mouse samples at 1:1000 (fig 3i). Commun Biol (2021) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 3i
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3021) was used in western blot on mouse samples at 1:1000 (fig 3i). Commun Biol (2021) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; loading ...; fig 3d
Cell Signaling Technology IGF-IR antibody (CST, 3024) was used in western blot on mouse samples (fig 3d). Sci Rep (2020) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; mouse; loading ...; fig 3d
Cell Signaling Technology IGF-IR antibody (CST, 9750) was used in western blot on mouse samples (fig 3d). Sci Rep (2020) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; 1:100; loading ...
Cell Signaling Technology IGF-IR antibody (CST, 19H7) was used in western blot on human samples at 1:100. Dev Cell (2020) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig 5a, 5b
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3024) was used in western blot on human samples (fig 5a, 5b). J Hematol Oncol (2020) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; loading ...; fig 5a, 5b
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 9750) was used in western blot on human samples (fig 5a, 5b). J Hematol Oncol (2020) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s3h
  • western blot; rat; 1:1000; loading ...; fig 4a
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3027) was used in western blot on mouse samples at 1:1000 (fig s3h) and in western blot on rat samples at 1:1000 (fig 4a). Sci Adv (2020) ncbi
monoclonal (D6D5L)
  • western blot; human; loading ...; fig 3a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, D6D5L) was used in western blot on human samples (fig 3a). Cells (2020) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:1000; loading ...; fig 5e, 5f, 5g
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on mouse samples at 1:1000 (fig 5e, 5f, 5g). elife (2019) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; 1:1000; loading ...; fig 2b
Cell Signaling Technology IGF-IR antibody (Cell signaling, 19H7) was used in western blot on human samples at 1:1000 (fig 2b). elife (2019) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 9750) was used in western blot on human samples (fig 3b). Breast Cancer Res (2019) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot knockout validation; mouse; 1:1000; loading ...; fig 1a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot knockout validation on mouse samples at 1:1000 (fig 1a). PLoS ONE (2019) ncbi
domestic rabbit polyclonal
  • chromatin immunoprecipitation; human; loading ...; fig 2g
  • immunoprecipitation; mouse; loading ...; fig 1c
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in chromatin immunoprecipitation on human samples (fig 2g) and in immunoprecipitation on mouse samples (fig 1c). Cell (2019) ncbi
domestic rabbit monoclonal (111A9)
  • western blot; human; 1:2000; loading ...; fig 7d
Cell Signaling Technology IGF-IR antibody (CST, 3018) was used in western blot on human samples at 1:2000 (fig 7d). elife (2019) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; rat; 1:1000; loading ...; fig 4f
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on rat samples at 1:1000 (fig 4f). Br J Pharmacol (2019) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:500; loading ...; fig 1k
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3024) was used in western blot on mouse samples at 1:500 (fig 1k). J Biol Chem (2018) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig s10f
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples (fig s10f). Nat Med (2018) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig s10f
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in western blot on human samples (fig s10f). Nat Med (2018) ncbi
domestic rabbit monoclonal (DA7A8)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig s5a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3918) was used in immunohistochemistry - paraffin section on mouse samples (fig s5a). Mol Cancer Res (2018) ncbi
domestic rabbit monoclonal (19H7)
  • other; human; loading ...; fig 4c
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit polyclonal
  • other; human; loading ...; fig 4c
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in other on human samples (fig 4c). Cancer Cell (2018) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024S) was used in western blot on mouse samples (fig 3a). Biochem Biophys Res Commun (2017) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; mouse; loading ...; fig 2f
Cell Signaling Technology IGF-IR antibody (Cell signaling, 9750) was used in western blot on mouse samples (fig 2f). Cancer Res (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; loading ...; fig 2f
Cell Signaling Technology IGF-IR antibody (Cell signaling, 6113) was used in western blot on mouse samples (fig 2f). Cancer Res (2017) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; loading ...; fig 3i
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750S) was used in western blot on human samples (fig 3i). Cell (2017) ncbi
domestic rabbit polyclonal
  • western blot; mouse; fig 7a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in western blot on mouse samples (fig 7a). Nat Commun (2017) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; mouse; fig 3a
  • western blot; human; loading ...; fig 4a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot on mouse samples (fig 3a) and in western blot on human samples (fig 4a). Sci Signal (2017) ncbi
domestic rabbit monoclonal (111A9)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology IGF-IR antibody (Cell signaling, 3018) was used in western blot on mouse samples (fig 3a). Mol Biol Cell (2017) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; loading ...; fig 3a
Cell Signaling Technology IGF-IR antibody (Cell signaling, 3024) was used in western blot on mouse samples (fig 3a). Mol Biol Cell (2017) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:500; fig 5a
Cell Signaling Technology IGF-IR antibody (Cell signaling, 3024) was used in western blot on mouse samples at 1:500 (fig 5a). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig 1a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3021) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1a). Oncotarget (2017) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:1000; fig 5d-f
In order to test if Fsp27 silencing improves obesity, fatty liver, and glycemic control, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on mouse samples at 1:1000 (fig 5d-f). J Lipid Res (2017) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; hamsters; fig 1g
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on hamsters samples (fig 1g). Nature (2016) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; hamsters; fig 1b
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot on hamsters samples (fig 1b). Nature (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; fig 2c
In order to discover a role for CRIM1 in mediating cardiac endothelial cell development, Cell Signaling Technology IGF-IR antibody (Cell signaling, 3024S) was used in western blot on human samples (fig 2c). J Mol Histol (2017) ncbi
domestic rabbit monoclonal (19H7)
  • ELISA; human; loading ...
In order to generate and characterize an antibody that is specific for the insulin receptor and evaluate its effect on diabetic pathogenesis, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in ELISA on human samples . Diabetes (2017) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig 4a
In order to identify autophagy-inducing phytochemicals, Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3024) was used in western blot on human samples (fig 4a). Autophagy (2017) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig 3b
In order to demonstrate that entinostat targets SALL4-positive lung cancer, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 3b
In order to demonstrate that entinostat targets SALL4-positive lung cancer, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in western blot on human samples (fig 3b). Oncotarget (2016) ncbi
domestic rabbit monoclonal (C14A11)
  • immunocytochemistry; rat; 1:50; loading ...; fig 1b
In order to provide a mechanistic link between three early polarity events needed for neuronal polarity, Cell Signaling Technology IGF-IR antibody (Cell Signaling, C14A11) was used in immunocytochemistry on rat samples at 1:50 (fig 1b). Mol Neurobiol (2017) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...
  • western blot; human; 1:1000; loading ...; fig 5a
In order to delineate the mechanism for lung tumorigenesis by a tobacco-specific carcinogen, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in immunohistochemistry - paraffin section on human samples and in western blot on human samples at 1:1000 (fig 5a). Nat Commun (2016) ncbi
domestic rabbit monoclonal (19H7)
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig s23
  • immunocytochemistry; human; 1:200; fig 2f
  • western blot; human; 1:1000; loading ...; fig 2b
In order to delineate the mechanism for lung tumorigenesis by a tobacco-specific carcinogen, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig s23), in immunocytochemistry on human samples at 1:200 (fig 2f) and in western blot on human samples at 1:1000 (fig 2b). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in western blot on human samples at 1:1000 (fig 2). Sci Rep (2016) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; 1:1000; loading ...; fig 3f
In order to determine if the extracellular matrix components of human skin fibroblasts change under non-stretch, static stretch, or cyclic stretch conditions, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot on human samples at 1:1000 (fig 3f). Exp Ther Med (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig 6A
In order to study the contribution of the heregulin-1/HER3-driven pathway to hepatocellular carcinoma, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples (fig 6A). J Exp Clin Cancer Res (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig 2a
In order to assess the importance of the IGF1R tyrosine kinase in triple-negative gastric cancer with and without oncogenic KRAS, BRAF or PI3K3CA mutations, Cell Signaling Technology IGF-IR antibody (Cell signaling, 3024) was used in western blot on human samples (fig 2a). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:50; loading ...; fig st1
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig st1). Oncotarget (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4c
Cell Signaling Technology IGF-IR antibody (cell signaling, 3027S) was used in western blot on human samples (fig 4c). Sci Rep (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; fig 2
In order to utilize a novel targe for type 2 diabetes and regulate the effects of GPR21, Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3024) was used in western blot on human samples (fig 2). Sci Rep (2016) ncbi
domestic rabbit monoclonal (19H7)
  • other; human; fig 7
In order to research a novel method of differential ligand activation and phosphatase-mediated deactivation of insulin receptor tyrosine-specific phosphorylation, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in other on human samples (fig 7). Cell Signal (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; mouse
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3027) was used in immunocytochemistry on mouse samples . Mol Metab (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; fig 5
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on mouse samples (fig 5). J Clin Invest (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:1000; fig 1
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, cst-3024) was used in western blot on mouse samples at 1:1000 (fig 1) and in western blot on human samples at 1:1000 (fig 3). Nat Cell Biol (2016) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; mouse; 1:1000; fig 1
  • western blot; human; 1:1000; fig 3
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, cst-9750) was used in western blot on mouse samples at 1:1000 (fig 1) and in western blot on human samples at 1:1000 (fig 3). Nat Cell Biol (2016) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; fig 1
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3027) was used in immunohistochemistry on mouse samples (fig 1). Neuron (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 4
Cell Signaling Technology IGF-IR antibody (Cell signaling, 3027) was used in western blot on human samples (fig 4). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; fig 4
Cell Signaling Technology IGF-IR antibody (Cell signaling, 3024) was used in western blot on human samples (fig 4). Mol Cancer (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; fig 5
In order to study the role of MAML3 in proliferation and retinoic acid-mediated differentiation, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples (fig 5). Mol Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
In order to study the role of MAML3 in proliferation and retinoic acid-mediated differentiation, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3027) was used in western blot on human samples (fig 5). Mol Cancer Res (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:50; loading ...; fig 1b
In order to demonstrate that receptor tyrosine kinase-like orphan receptor 1 is a scaffold for cavin-1 and caveolin-1, Cell Signaling Technology IGF-IR antibody (Cell Signalling, 3027) was used in western blot on human samples at 1:50 (fig 1b). Nat Commun (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; 1:50; loading ...; fig 1b
In order to demonstrate that receptor tyrosine kinase-like orphan receptor 1 is a scaffold for cavin-1 and caveolin-1, Cell Signaling Technology IGF-IR antibody (Cell Signalling, 3024) was used in western blot on human samples at 1:50 (fig 1b). Nat Commun (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; fig 6e
In order to study the effect of insulin on tumor necrosis factor-dependent early osteoarthritic in obesity and type 2 diabetes mellitus, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples (fig 6e). Arthritis Rheumatol (2016) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig 1a
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples (fig 1a). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human
In order to examine the role of asporin in the early stages of eye development in Xenopus embryos, Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 9750) was used in western blot on human samples . Development (2015) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:1000; fig 1
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on mouse samples at 1:1000 (fig 1). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; mouse; 1:1000; fig 7
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot on mouse samples at 1:1000 (fig 7). Nat Commun (2015) ncbi
domestic rabbit monoclonal (19H7)
  • immunohistochemistry; mouse
  • western blot; mouse
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3024) was used in immunohistochemistry on mouse samples and in western blot on mouse samples . Mol Neurodegener (2015) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; fig 5
In order to investigate how loss of RE-1 Silencing Transcription Factor affects breast cancer, Cell Signaling Technology IGF-IR antibody (cell signaling, 9750) was used in western blot on human samples (fig 5). Mol Cell Biol (2015) ncbi
domestic rabbit monoclonal (111A9)
  • western blot; human; fig 3
Cell Signaling Technology IGF-IR antibody (Cell signaling, 3018) was used in western blot on human samples (fig 3). MAbs (2015) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; fig 3
Cell Signaling Technology IGF-IR antibody (Cell signaling, 3024) was used in western blot on human samples (fig 3). MAbs (2015) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; loading ...; fig 1c,2a,2b,2c,2d,2e,2f,2g,2i,2j
In order to study mechanisms that confer resistance to therapeutic interventions in the insulin-like growth factor receptor pathway, Cell Signaling Technology IGF-IR antibody (CST, 3024) was used in western blot on human samples (fig 1c,2a,2b,2c,2d,2e,2f,2g,2i,2j). Mol Cancer (2015) ncbi
domestic rabbit monoclonal (111A9)
  • western blot; human; 1:1000; fig 2
Cell Signaling Technology IGF-IR antibody (Cell Signaling Tech, 3018) was used in western blot on human samples at 1:1000 (fig 2). Oncotarget (2015) ncbi
domestic rabbit monoclonal (DA7A8)
  • western blot; human; 1:1000; fig 1
Cell Signaling Technology IGF-IR antibody (Cell Signaling Tech, 3918) was used in western blot on human samples at 1:1000 (fig 1). Oncotarget (2015) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human; fig 4
In order to determine the contribution of ESR2 to medulloblastoma growth in vitro and in vivo, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in western blot on human samples (fig 4). Endocrinology (2015) ncbi
domestic rabbit monoclonal (D23H3)
  • immunohistochemistry - paraffin section; mouse; 2 ug/ml; fig 4
  • western blot; mouse; 0.2 ug/ml; fig 4
In order to determine the contribution of ESR2 to medulloblastoma growth in vitro and in vivo, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in immunohistochemistry - paraffin section on mouse samples at 2 ug/ml (fig 4) and in western blot on mouse samples at 0.2 ug/ml (fig 4). Endocrinology (2015) ncbi
domestic rabbit monoclonal (19H7)
  • immunocytochemistry; human
  • western blot; human
In order to study Donohue syndrome in mesenchymal progenitor cells derived from human patients, Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024) was used in immunocytochemistry on human samples and in western blot on human samples . Endocrinology (2015) ncbi
domestic rabbit monoclonal (DA7A8)
  • western blot; human
In order to examine the relationship of IGF1R and PI3Kis in chemotherapy resistance of cancer, Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3918) was used in western blot on human samples . Cancer Sci (2015) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; human; 1:1000
Cell Signaling Technology IGF-IR antibody (Cell Signaling, D23H3) was used in western blot on human samples at 1:1000. Front Endocrinol (Lausanne) (2014) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human
Cell Signaling Technology IGF-IR antibody (Cell Signaling Technology, 3024) was used in western blot on human samples . PLoS ONE (2014) ncbi
domestic rabbit monoclonal (DA7A8)
  • western blot; human
Cell Signaling Technology IGF-IR antibody (Cell Signaling Biotechnology, 3918) was used in western blot on human samples . Cell Signal (2014) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; mouse; 1:1000
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024S) was used in western blot on mouse samples at 1:1000. J Biol Chem (2014) ncbi
domestic rabbit monoclonal (D23H3)
  • western blot; mouse
  • western blot; human
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 9750) was used in western blot on mouse samples and in western blot on human samples . Invest Ophthalmol Vis Sci (2013) ncbi
domestic rabbit monoclonal (19H7)
  • western blot; human
Cell Signaling Technology IGF-IR antibody (Cell Signaling, 3024S) was used in western blot on human samples . Mol Cell Biol (2013) ncbi
BD Biosciences
mouse monoclonal (1H7)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences IGF-IR antibody (BD Pharmingen, 1H7) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (1H7)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences IGF-IR antibody (BD, 555999) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (1H7)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BD Biosciences IGF-IR antibody (BD Pharmingen, 555999) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (1H7)
  • flow cytometry; human
In order to describe the phase II trial using teprotumumab (RV 001, R1507) to treat patients with active thyroid-associated ophthalmopathy, BD Biosciences IGF-IR antibody (BD Biosciences, 555999) was used in flow cytometry on human samples . J Clin Endocrinol Metab (2014) ncbi
Articles Reviewed
  1. Park J, Li J, Mayer J, Ball K, Wu J, Hall C, et al. Activation of the insulin receptor by an insulin mimetic peptide. Nat Commun. 2022;13:5594 pubmed publisher
  2. Marei H, Tsai W, Kee Y, Ruiz K, He J, Cox C, et al. Antibody targeting of E3 ubiquitin ligases for receptor degradation. Nature. 2022;610:182-189 pubmed publisher
  3. Cyra M, Schulte M, Berthold R, Heinst L, Jansen E, Gr xfc newald I, et al. SS18-SSX drives CREB activation in synovial sarcoma. Cell Oncol (Dordr). 2022;45:399-413 pubmed publisher
  4. Rauskolb S, Andreska T, Fries S, von Collenberg C, Blum R, Monoranu C, et al. Insulin-like growth factor 5 associates with human Aß plaques and promotes cognitive impairment. Acta Neuropathol Commun. 2022;10:68 pubmed publisher
  5. Miller L, Tarantini S, Nyúl Tóth Á, Johnston M, Martin T, Bullen E, et al. Increased Susceptibility to Cerebral Microhemorrhages Is Associated With Imaging Signs of Microvascular Degeneration in the Retina in an Insulin-Like Growth Factor 1 Deficient Mouse Model of Accelerated Aging. Front Aging Neurosci. 2022;14:788296 pubmed publisher
  6. Weiss J, Hunter M, CRUZ N, Baggiolini A, Tagore M, Ma Y, et al. Anatomic position determines oncogenic specificity in melanoma. Nature. 2022;604:354-361 pubmed publisher
  7. Yeh C, Liu H, Lee M, Leu Y, Chiang W, Chang H, et al. Phytochemical‑rich herbal formula ATG‑125 protects against sucrose‑induced gastrocnemius muscle atrophy by rescuing Akt signaling and improving mitochondrial dysfunction in young adult mice. Mol Med Rep. 2022;25: pubmed publisher
  8. Vichas A, Riley A, Nkinsi N, Kamlapurkar S, Parrish P, Lo A, et al. Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. Nat Commun. 2021;12:4789 pubmed publisher
  9. Prekovic S, Schuurman K, Mayayo Peralta I, Manjón A, Buijs M, Yavuz S, et al. Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer. Nat Commun. 2021;12:4360 pubmed publisher
  10. Wang W, Lu G, Liu H, Xiong Z, Leung H, Cao R, et al. Pten Regulates Cardiomyocyte Differentiation by Modulating Non-CG Methylation via Dnmt3. Adv Sci (Weinh). 2021;:e2100849 pubmed publisher
  11. Achlaug L, Somri Gannam L, Meisel Sharon S, Sarfstein R, Dixit M, Yakar S, et al. ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease. Front Endocrinol (Lausanne). 2021;12:688104 pubmed publisher
  12. Wu Q, Tian A, Li B, Leduc M, Forveille S, Hamley P, et al. IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms. J Immunother Cancer. 2021;9: pubmed publisher
  13. López Gambero A, Rosell Valle C, Medina Vera D, Navarro J, Vargas A, Rivera P, et al. A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse. Int J Mol Sci. 2021;22: pubmed publisher
  14. Luo L, Zhang Z, Qiu N, Ling L, Jia X, Song Y, et al. Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer. Nat Commun. 2021;12:2699 pubmed publisher
  15. Jacques S, Arjomand A, Per xe9 e H, Collins P, Mayer A, Lavergne A, et al. Dual-specificity phosphatase 3 deletion promotes obesity, non-alcoholic steatohepatitis and hepatocellular carcinoma. Sci Rep. 2021;11:5817 pubmed publisher
  16. Wang L, Liu Y, Stratigopoulos G, Panigrahi S, Sui L, Zhang Y, et al. Bardet-Biedl syndrome proteins regulate intracellular signaling and neuronal function in patient-specific iPSC-derived neurons. J Clin Invest. 2021;131: pubmed publisher
  17. Musicant A, Parag Sharma K, Gong W, Sengupta M, Chatterjee A, Henry E, et al. CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition. Cell Rep. 2021;34:108768 pubmed publisher
  18. Tangseefa P, Martin S, Chin P, Breen J, Mah C, Baldock P, et al. The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin. Bone Res. 2021;9:10 pubmed publisher
  19. Isomura H, Taguchi A, Kajino T, Asai N, Nakatochi M, Kato S, et al. Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF-1α regulator. Cancer Sci. 2021;: pubmed publisher
  20. Okawa E, Gupta M, Kahraman S, Goli P, Sakaguchi M, Hu J, et al. Essential roles of insulin and IGF-1 receptors during embryonic lineage development. Mol Metab. 2021;47:101164 pubmed publisher
  21. Stojakovic A, Trushin S, Sheu A, Khalili L, Chang S, Li X, et al. Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP/PS1 female mice. Commun Biol. 2021;4:61 pubmed publisher
  22. Grundmann S, Schutkowski A, Berger C, Baur A, König B, Stangl G. High-phosphorus diets reduce aortic lesions and cardiomyocyte size and modify lipid metabolism in Ldl receptor knockout mice. Sci Rep. 2020;10:20748 pubmed publisher
  23. Jin Y, Cheng X, Huang X, Ding F, Lee S, Wang F, et al. The role of Hrd1 in ultraviolet (UV) radiation induced photoaging. Aging (Albany NY). 2020;12:21273-21289 pubmed publisher
  24. Ferreira Mendes J, de Faro Valverde L, Torres Andion Vidal M, Paredes B, Coelho P, Allahdadi K, et al. Effects of IGF-1 on Proliferation, Angiogenesis, Tumor Stem Cell Populations and Activation of AKT and Hedgehog Pathways in Oral Squamous Cell Carcinoma. Int J Mol Sci. 2020;21: pubmed publisher
  25. Dabelsteen S, Pallesen E, Marinova I, Nielsen M, Adamopoulou M, Rømer T, et al. Essential Functions of Glycans in Human Epithelia Dissected by a CRISPR-Cas9-Engineered Human Organotypic Skin Model. Dev Cell. 2020;54:669-684.e7 pubmed publisher
  26. Zhou X, Chen N, Xu H, Zhou X, Wang J, Fang X, et al. Regulation of Hippo-YAP signaling by insulin-like growth factor-1 receptor in the tumorigenesis of diffuse large B-cell lymphoma. J Hematol Oncol. 2020;13:77 pubmed publisher
  27. Bi H, Zhang X, Zhang Y, Xie X, Xia Y, Du J, et al. The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor. Sci Adv. 2020;6:eaax4826 pubmed publisher
  28. Rigiracciolo D, Nohata N, Lappano R, Cirillo F, Talia M, Scordamaglia D, et al. IGF-1/IGF-1R/FAK/YAP Transduction Signaling Prompts Growth Effects in Triple-Negative Breast Cancer (TNBC) Cells. Cells. 2020;9: pubmed publisher
  29. Zhang Z, Le K, La Placa D, Armstrong B, Miller M, Shively J. CXCR2 specific endocytosis of immunomodulatory peptide LL-37 in human monocytes and formation of LL-37 positive large vesicles in differentiated monoosteophils. Bone Rep. 2020;12:100237 pubmed publisher
  30. Bella P, Farini A, Banfi S, Parolini D, Tonna N, Meregalli M, et al. Blockade of IGF2R improves muscle regeneration and ameliorates Duchenne muscular dystrophy. EMBO Mol Med. 2020;12:e11019 pubmed publisher
  31. Helsley R, Varadharajan V, Brown A, Gromovsky A, Schugar R, Ramachandiran I, et al. Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease. elife. 2019;8: pubmed publisher
  32. Uchikawa E, Choi E, Shang G, Yu H, Bai X. Activation mechanism of the insulin receptor revealed by cryo-EM structure of the fully liganded receptor-ligand complex. elife. 2019;8: pubmed publisher
  33. Hori A, Shimoda M, Naoi Y, Kagara N, Tanei T, Miyake T, et al. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer. Breast Cancer Res. 2019;21:88 pubmed publisher
  34. Jin J, Ravindran P, Di Meo D, Püschel A. Igf1R/InsR function is required for axon extension and corpus callosum formation. PLoS ONE. 2019;14:e0219362 pubmed publisher
  35. Hancock M, Meyer R, Mistry M, Khetani R, Wagschal A, Shin T, et al. Insulin Receptor Associates with Promoters Genome-wide and Regulates Gene Expression. Cell. 2019;177:722-736.e22 pubmed publisher
  36. Xu H, Xu S, Xie S, Zhang Y, Yang J, Zhang W, et al. MicroRNA-122 supports robust innate immunity in hepatocytes by targeting the RTKs/STAT3 signaling pathway. elife. 2019;8: pubmed publisher
  37. Zhou X, Zhang R, Zou Z, Shen X, Xie T, Xu C, et al. Hypoglycaemic effects of glimepiride in sulfonylurea receptor 1 deficient rat. Br J Pharmacol. 2019;176:478-490 pubmed publisher
  38. Jones R, Franks S, Moorehead R. Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancer. PLoS ONE. 2018;13:e0206948 pubmed publisher
  39. Gubbiotti M, Seifert E, Rodeck U, Hoek J, Iozzo R. Metabolic reprogramming of murine cardiomyocytes during autophagy requires the extracellular nutrient sensor decorin. J Biol Chem. 2018;293:16940-16950 pubmed publisher
  40. Ruess D, Heynen G, Ciecielski K, Ai J, Berninger A, Kabacaoglu D, et al. Mutant KRAS-driven cancers depend on PTPN11/SHP2 phosphatase. Nat Med. 2018;24:954-960 pubmed publisher
  41. Park J, Kim I, Choi J, Lim H, Shin J, Kim Y, et al. AHNAK Loss in Mice Promotes Type II Pneumocyte Hyperplasia and Lung Tumor Development. Mol Cancer Res. 2018;16:1287-1298 pubmed publisher
  42. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed publisher
  43. Bekkering S, Arts R, Novakovic B, Kourtzelis I, van der Heijden C, Li Y, et al. Metabolic Induction of Trained Immunity through the Mevalonate Pathway. Cell. 2018;172:135-146.e9 pubmed publisher
  44. Wei X, Guo L, Liu Y, Zhou S, Liu Y, Dou X, et al. Synthesis of cytochrome c oxidase 1 (SCO1) inhibits insulin sensitivity by decreasing copper levels in adipocytes. Biochem Biophys Res Commun. 2017;491:814-820 pubmed publisher
  45. Akiel M, Guo C, Li X, Rajasekaran D, Mendoza R, Robertson C, et al. IGFBP7 Deletion Promotes Hepatocellular Carcinoma. Cancer Res. 2017;77:4014-4025 pubmed publisher
  46. Tawo R, Pokrzywa W, Kevei E, Akyuz M, Balaji V, Adrian S, et al. The Ubiquitin Ligase CHIP Integrates Proteostasis and Aging by Regulation of Insulin Receptor Turnover. Cell. 2017;169:470-482.e13 pubmed publisher
  47. Cai W, Sakaguchi M, Kleinridders A, Gonzalez Del Pino G, Dreyfuss J, O Neill B, et al. Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression. Nat Commun. 2017;8:14892 pubmed publisher
  48. Ting W, Huang C, Jiang C, Lin Y, Chung L, Shen C, et al. Treatment with 17?-Estradiol Reduced Body Weight and the Risk of Cardiovascular Disease in a High-Fat Diet-Induced Animal Model of Obesity. Int J Mol Sci. 2017;18: pubmed publisher
  49. CAROMILE L, Dortche K, Rahman M, Grant C, Stoddard C, Ferrer F, et al. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer. Sci Signal. 2017;10: pubmed publisher
  50. Chaudhari A, Gupta R, Patel S, Velingkaar N, Kondratov R. Cryptochromes regulate IGF-1 production and signaling through control of JAK2-dependent STAT5B phosphorylation. Mol Biol Cell. 2017;28:834-842 pubmed publisher
  51. Decourtye L, Mire E, Clemessy M, Heurtier V, Ledent T, Robinson I, et al. IGF-1 Induces GHRH Neuronal Axon Elongation during Early Postnatal Life in Mice. PLoS ONE. 2017;12:e0170083 pubmed publisher
  52. Björner S, Rosendahl A, Simonsson M, Markkula A, Jirström K, Borgquist S, et al. Combined and individual tumor-specific expression of insulin-like growth factor-I receptor, insulin receptor and phospho-insulin-like growth factor-I receptor/insulin receptor in primary breast cancer: Implications for prognosis in different treatmen. Oncotarget. 2017;8:9093-9107 pubmed publisher
  53. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  54. Li L, Byrd M, Doh K, Dixon P, Lee H, Tiwari S, et al. Absence of renal enlargement in fructose-fed proximal-tubule-select insulin receptor (IR), insulin-like-growth factor receptor (IGF1R) double knockout mice. Physiol Rep. 2016;4: pubmed
  55. Langhi C, Arias N, Rajamoorthi A, Basta J, Lee R, Baldán A. Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance. J Lipid Res. 2017;58:81-91 pubmed publisher
  56. Wang X, Cao Q, Yu L, Shi H, Xue B, Shi H. Epigenetic regulation of macrophage polarization and inflammation by DNA methylation in obesity. JCI Insight. 2016;1:e87748 pubmed publisher
  57. Han C, Juncadella I, Kinchen J, Buckley M, Klibanov A, Dryden K, et al. Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation. Nature. 2016;539:570-574 pubmed publisher
  58. Iyer S, Chhabra Y, Harvey T, Wang R, Chiu H, Smith A, et al. CRIM1 is necessary for coronary vascular endothelial cell development and homeostasis. J Mol Histol. 2017;48:53-61 pubmed publisher
  59. Cieniewicz A, Kirchner T, Hinke S, Nanjunda R, D AQUINO K, Boayke K, et al. Novel Monoclonal Antibody Is an Allosteric Insulin Receptor Antagonist That Induces Insulin Resistance. Diabetes. 2017;66:206-217 pubmed publisher
  60. Fan Y, Wang N, Rocchi A, Zhang W, Vassar R, Zhou Y, et al. Identification of natural products with neuronal and metabolic benefits through autophagy induction. Autophagy. 2017;13:41-56 pubmed publisher
  61. Yong K, Li A, Ou W, Hong C, Zhao W, Wang F, et al. Targeting SALL4 by entinostat in lung cancer. Oncotarget. 2016;7:75425-75440 pubmed publisher
  62. Oksdath M, Guil A, Grassi D, Sosa L, Quiroga S. The Motor KIF5C Links the Requirements of Stable Microtubules and IGF-1 Receptor Membrane Insertion for Neuronal Polarization. Mol Neurobiol. 2017;54:6085-6096 pubmed publisher
  63. Boo H, Min H, Jang H, Yun H, Smith J, Jin Q, et al. The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells. Nat Commun. 2016;7:12961 pubmed publisher
  64. Chen P, Qin L, Li G, Tellides G, Simons M. Fibroblast growth factor (FGF) signaling regulates transforming growth factor beta (TGF?)-dependent smooth muscle cell phenotype modulation. Sci Rep. 2016;6:33407 pubmed publisher
  65. Jiang M, Qiu J, Zhang L, Lu D, Long M, Chen L, et al. Changes in tension regulates proliferation and migration of fibroblasts by remodeling expression of ECM proteins. Exp Ther Med. 2016;12:1542-1550 pubmed
  66. Bassi D, Zhang J, Renner C, Klein Szanto A. Targeting proprotein convertases in furin-rich lung cancer cells results in decreased in vitro and in vivo growth. Mol Carcinog. 2017;56:1182-1188 pubmed publisher
  67. Buta C, Benabou E, Lequoy M, Régnault H, Wendum D, Meratbene F, et al. Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. J Exp Clin Cancer Res. 2016;35:126 pubmed publisher
  68. Hirakawa T, Yashiro M, Doi Y, Kinoshita H, Morisaki T, Fukuoka T, et al. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia. PLoS ONE. 2016;11:e0159912 pubmed publisher
  69. Saisana M, Griffin S, May F. Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation. Oncotarget. 2016;7:54445-54462 pubmed publisher
  70. Huber M, Falkenberg N, Hauck S, Priller M, Braselmann H, Feuchtinger A, et al. Cyr61 and YB-1 are novel interacting partners of uPAR and elevate the malignancy of triple-negative breast cancer. Oncotarget. 2016;7:44062-44075 pubmed publisher
  71. Svalina M, Kikuchi K, Abraham J, Lal S, Davare M, Settelmeyer T, et al. IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma. Sci Rep. 2016;6:27012 pubmed publisher
  72. Leonard S, Kinsella G, Benetti E, Findlay J. Regulating the effects of GPR21, a novel target for type 2 diabetes. Sci Rep. 2016;6:27002 pubmed publisher
  73. Allodi I, Comley L, Nichterwitz S, Nizzardo M, Simone C, Benitez J, et al. Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS. Sci Rep. 2016;6:25960 pubmed publisher
  74. Ting W, Yang J, Kuo C, Xiao Z, Lu X, Yeh Y, et al. Environmental tobacco smoke increases autophagic effects but decreases longevity associated with Sirt-1 protein expression in young C57BL mice hearts. Oncotarget. 2016;7:39017-39025 pubmed publisher
  75. Cieniewicz A, Cooper P, MCGEHEE J, Lingham R, Kihm A. Novel method demonstrates differential ligand activation and phosphatase-mediated deactivation of insulin receptor tyrosine-specific phosphorylation. Cell Signal. 2016;28:1037-47 pubmed publisher
  76. Boothe T, Lim G, Cen H, Skovsø S, Piske M, Li S, et al. Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells. Mol Metab. 2016;5:366-378 pubmed publisher
  77. Winnay J, Solheim M, Dirice E, Sakaguchi M, Noh H, Kang H, et al. PI3-kinase mutation linked to insulin and growth factor resistance in vivo. J Clin Invest. 2016;126:1401-12 pubmed publisher
  78. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  79. Park J, Lee J, Zhang Y, Hoffman R, Bouvet M. Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse models. Oncotarget. 2016;7:18262-8 pubmed publisher
  80. Mason J, Davison Versagli C, Leliaert A, Pape D, McCallister C, Zuo J, et al. Oncogenic Ras differentially regulates metabolism and anoikis in extracellular matrix-detached cells. Cell Death Differ. 2016;23:1271-82 pubmed publisher
  81. Ding M, Bruick R, Yu Y. Secreted IGFBP5 mediates mTORC1-dependent feedback inhibition of IGF-1 signalling. Nat Cell Biol. 2016;18:319-27 pubmed publisher
  82. Gazit N, Vertkin I, Shapira I, Helm M, Slomowitz E, Sheiba M, et al. IGF-1 Receptor Differentially Regulates Spontaneous and Evoked Transmission via Mitochondria at Hippocampal Synapses. Neuron. 2016;89:583-97 pubmed publisher
  83. Luey B, May F. Insulin-like growth factors are essential to prevent anoikis in oestrogen-responsive breast cancer cells: importance of the type I IGF receptor and PI3-kinase/Akt pathway. Mol Cancer. 2016;15:8 pubmed publisher
  84. Heynen G, Nevedomskaya E, Palit S, Jagalur Basheer N, Lieftink C, Schlicker A, et al. Mastermind-Like 3 Controls Proliferation and Differentiation in Neuroblastoma. Mol Cancer Res. 2016;14:411-22 pubmed publisher
  85. Park J, Murakami T, Lee J, Zhang Y, Hoffman R, Bouvet M. Fluorescent-Antibody Targeting of Insulin-Like Growth Factor-1 Receptor Visualizes Metastatic Human Colon Cancer in Orthotopic Mouse Models. PLoS ONE. 2016;11:e0146504 pubmed publisher
  86. Yamaguchi T, Lu C, Ida L, Yanagisawa K, Usukura J, Cheng J, et al. ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1. Nat Commun. 2016;7:10060 pubmed publisher
  87. Hamada D, Maynard R, Schott E, Drinkwater C, Ketz J, Kates S, et al. Suppressive Effects of Insulin on Tumor Necrosis Factor-Dependent Early Osteoarthritic Changes Associated With Obesity and Type 2 Diabetes Mellitus. Arthritis Rheumatol. 2016;68:1392-402 pubmed publisher
  88. Xu Y, Huang J, Ma L, Shan J, Shen J, Yang Z, et al. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Cancer Lett. 2016;371:171-81 pubmed publisher
  89. Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong R, Miller K, et al. Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development. Cancer Discov. 2016;6:188-201 pubmed publisher
  90. Goto A, Egawa T, Sakon I, Oshima R, Ito K, Serizawa Y, et al. Heat stress acutely activates insulin-independent glucose transport and 5'-AMP-activated protein kinase prior to an increase in HSP72 protein in rat skeletal muscle. Physiol Rep. 2015;3: pubmed publisher
  91. Ramcharan R, Aleksic T, Kamdoum W, Gao S, Pfister S, Tanner J, et al. IGF-1R inhibition induces schedule-dependent sensitization of human melanoma to temozolomide. Oncotarget. 2015;6:39877-90 pubmed publisher
  92. Luehders K, Sasai N, Davaapil H, Kurosawa Yoshida M, Hiura H, Brah T, et al. The small leucine-rich repeat secreted protein Asporin induces eyes in Xenopus embryos through the IGF signalling pathway. Development. 2015;142:3351-61 pubmed publisher
  93. Nemazanyy I, Montagnac G, Russell R, Morzyglod L, Burnol A, Guan K, et al. Class III PI3K regulates organismal glucose homeostasis by providing negative feedback on hepatic insulin signalling. Nat Commun. 2015;6:8283 pubmed publisher
  94. Jackson R, Tilokee E, Latham N, Mount S, Rafatian G, Strydhorst J, et al. Paracrine Engineering of Human Cardiac Stem Cells With Insulin-Like Growth Factor 1 Enhances Myocardial Repair. J Am Heart Assoc. 2015;4:e002104 pubmed publisher
  95. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  96. Krishnan N, Krishnan K, Connors C, Choy M, Page R, Peti W, et al. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J Clin Invest. 2015;125:3163-77 pubmed publisher
  97. Tan X, Xue Y, Ma T, Wang X, Li J, Lan L, et al. Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Mol Neurodegener. 2015;10:24 pubmed publisher
  98. Meyer K, Albaugh B, Schoenike B, Roopra A. Type 1 Insulin-Like Growth Factor Receptor/Insulin Receptor Substrate 1 Signaling Confers Pathogenic Activity on Breast Tumor Cells Lacking REST. Mol Cell Biol. 2015;35:2991-3004 pubmed publisher
  99. Shen Y, Zeng L, Novosyadlyy R, Forest A, Zhu A, Korytko A, et al. A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation. MAbs. 2015;7:931-45 pubmed publisher
  100. Min H, Yun H, Lee J, Lee H, Cho J, Jang H, et al. Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer. Mol Cancer. 2015;14:113 pubmed publisher
  101. Sharon C, Baranwal S, Patel N, Rodriguez Agudo D, Pandak W, Majumdar A, et al. Inhibition of insulin-like growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonate-isoprenoid pathway in vitro and in vivo. Oncotarget. 2015;6:15332-47 pubmed
  102. Bettaieb A, Jiang J, Sasaki Y, Chao T, Kiss Z, Chen X, et al. Hepatocyte Nicotinamide Adenine Dinucleotide Phosphate Reduced Oxidase 4 Regulates Stress Signaling, Fibrosis, and Insulin Sensitivity During Development of Steatohepatitis in Mice. Gastroenterology. 2015;149:468-80.e10 pubmed publisher
  103. Cookman C, Belcher S. Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma. Endocrinology. 2015;156:2395-408 pubmed publisher
  104. Vishwamitra D, Curry C, Alkan S, Song Y, Gallick G, Kaseb A, et al. The transcription factors Ik-1 and MZF1 downregulate IGF-IR expression in NPM-ALK⁺ T-cell lymphoma. Mol Cancer. 2015;14:53 pubmed publisher
  105. Balhara B, Burkart A, Topcu V, Lee Y, Cowan C, Kahn C, et al. Severe insulin resistance alters metabolism in mesenchymal progenitor cells. Endocrinology. 2015;156:2039-48 pubmed publisher
  106. Cabail M, Li S, Lemmon E, Bowen M, Hubbard S, Miller W. The insulin and IGF1 receptor kinase domains are functional dimers in the activated state. Nat Commun. 2015;6:6406 pubmed publisher
  107. Chen C, Zhao Z, Liu Y, Mu D. microRNA-99a is downregulated and promotes proliferation, migration and invasion in non-small cell lung cancer A549 and H1299 cells. Oncol Lett. 2015;9:1128-1134 pubmed
  108. Isoyama S, Kajiwara G, Tamaki N, Okamura M, Yoshimi H, Nakamura N, et al. Basal expression of insulin-like growth factor 1 receptor determines intrinsic resistance of cancer cells to a phosphatidylinositol 3-kinase inhibitor ZSTK474. Cancer Sci. 2015;106:171-8 pubmed publisher
  109. Wein N, Vulin A, Falzarano M, Szigyarto C, Maiti B, Findlay A, et al. Translation from a DMD exon 5 IRES results in a functional dystrophin isoform that attenuates dystrophinopathy in humans and mice. Nat Med. 2014;20:992-1000 pubmed publisher
  110. George S, Vishwamitra D, Manshouri R, Shi P, Amin H. The ALK inhibitor ASP3026 eradicates NPM-ALK? T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model. Oncotarget. 2014;5:5750-63 pubmed
  111. Chen H, Mester T, Raychaudhuri N, Kauh C, Gupta S, Smith T, et al. Teprotumumab, an IGF-1R blocking monoclonal antibody inhibits TSH and IGF-1 action in fibrocytes. J Clin Endocrinol Metab. 2014;99:E1635-40 pubmed publisher
  112. Zeng L, Holly J, Perks C. Effects of physiological levels of the green tea extract epigallocatechin-3-gallate on breast cancer cells. Front Endocrinol (Lausanne). 2014;5:61 pubmed publisher
  113. Subramani R, Lopez Valdez R, Arumugam A, Nandy S, Boopalan T, Lakshmanaswamy R. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis. PLoS ONE. 2014;9:e97016 pubmed publisher
  114. Liu J, Druta M, Shibata D, Coppola D, Boler I, Elahi A, et al. Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?. J Geriatr Oncol. 2014;5:40-8 pubmed publisher
  115. Leiphrakpam P, Rajput A, Mathiesen M, Agarwal E, Lazenby A, Are C, et al. Ezrin expression and cell survival regulation in colorectal cancer. Cell Signal. 2014;26:868-79 pubmed publisher
  116. Ziegler A, Chidambaram S, Forbes B, Wood T, Levison S. Insulin-like growth factor-II (IGF-II) and IGF-II analogs with enhanced insulin receptor-a binding affinity promote neural stem cell expansion. J Biol Chem. 2014;289:4626-33 pubmed publisher
  117. Fuentes T, Appleby N, Tsay E, Martinez J, Bailey L, Hasaniya N, et al. Human neonatal cardiovascular progenitors: unlocking the secret to regenerative ability. PLoS ONE. 2013;8:e77464 pubmed publisher
  118. Wang Y, Zhao X, Shi D, Chen P, Yu Y, Yang L, et al. Overexpression of SIRT1 promotes high glucose-attenuated corneal epithelial wound healing via p53 regulation of the IGFBP3/IGF-1R/AKT pathway. Invest Ophthalmol Vis Sci. 2013;54:3806-14 pubmed publisher
  119. Jacobo S, DeAngelis M, Kim I, Kazlauskas A. Age-related macular degeneration-associated silent polymorphisms in HtrA1 impair its ability to antagonize insulin-like growth factor 1. Mol Cell Biol. 2013;33:1976-90 pubmed publisher
  120. Gallardo A, Lerma E, Escuin D, Tibau A, Munoz J, Ojeda B, et al. Increased signalling of EGFR and IGF1R, and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Br J Cancer. 2012;106:1367-73 pubmed publisher
  121. Vishwamitra D, Li Y, Wilson D, Manshouri R, Curry C, Shi B, et al. MicroRNA 96 is a post-transcriptional suppressor of anaplastic lymphoma kinase expression. Am J Pathol. 2012;180:1772-80 pubmed publisher
  122. Langner C, Ratschek M, Rehak P, Tsybrovskyy O, Zigeuner R. The pT1a and pT1b category subdivision in renal cell carcinoma: is it reflected by differences in tumour biology?. BJU Int. 2005;95:310-4 pubmed